Richard William Scalzo - 10 Dec 2021 Form 4 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Vice President of Accounting and Administration and Treasurer
Signature
/s/ Richard Scalzo
Issuer symbol
DYN
Transactions as of
10 Dec 2021
Net transactions value
$0
Form type
4
Filing time
14 Dec 2021, 15:23:56 UTC
Previous filing
22 Sep 2021
Next filing
14 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DYN Common Stock Award $0 +16,696 +157% $0.000000 27,302 10 Dec 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DYN Stock Option (right to buy) Award $0 +25,044 $0.000000 25,044 10 Dec 2021 Common Stock 25,044 $13.12 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of shares of Common Stock issuable under 16,696 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in equal quarterly installments over four years with the first installment vesting on March 10, 2022.
F2 Includes 25,295 unvested RSUs. Each unvested RSU represents the right to receive one share of Common Stock upon vesting.
F3 This option was granted on December 10, 2021. The shares underlying the option are scheduled to vest over four years in equal monthly installments through December 10, 2025.

Remarks:

Vice President of Accounting and Administration and Treasurer